Skip to main content
SpringerLink
Log in

Umbilical Cord Blood Transplantation

  • Chapter
  • First Online:
Hematopoietic Stem Cell Transplantation

Part of the book series: Cancer Treatment and Research ((CTAR,volume 144))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ende M, Ende N. Hematopoietic transplantation by means of fetal (cord) blood. Va Med J. 1972;99:276–80.

    CAS  Google Scholar 

  2. Koike K. Cryopreservation of pluripotent and committed hemopoietic progenitor cells from human bone marrow and cord blood. Acta Paediatr Jpn. 1983;25:275.

    Google Scholar 

  3. Vidal JB. Nature and characterization of granulocyte-macrophage precursors in cord blood. Universtiy of Valencia School of Medicine (Doctoral Dissertation); 1985.

    Google Scholar 

  4. Broxmeyer HE, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 1989;86:3828–32.

    Google Scholar 

  5. Broxmeyer HE, et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA. 1992;89:4109–13.

    Google Scholar 

  6. Gluckman E, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–8.

    Article  PubMed  CAS  Google Scholar 

  7. Cardoso AA, et al. Release from quiescence of CD34+ CD38– human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA. 1993;90:8707–11.

    Google Scholar 

  8. Yahata T, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003;101:2905–13.

    Article  PubMed  CAS  Google Scholar 

  9. Broxmeyer HE. Introduction: The past, present, and future of cord blood transplantation. In: Broxmeyer HE, editor. Cellular characteristics of cord blood and cord blood transplantation. Bethesda, MA: AABB Press; 1998. p. 1–9.

    Google Scholar 

  10. Hannet I, et al. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today. 1992;13:215, 218.

    Article  PubMed  CAS  Google Scholar 

  11. Rainaut M, et al. Characterization of mononuclear cell subpopulations in normal fetal peripheral blood. Hum Immunol. 1987;18:331–7.

    Article  PubMed  CAS  Google Scholar 

  12. Clement LT, Vink PE, Bradley GE. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J Immunol. 1990;145:102–8.

    PubMed  CAS  Google Scholar 

  13. Godfrey WR, et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005;105:750–8.

    Article  PubMed  CAS  Google Scholar 

  14. Cohen JL, et al. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196:401–6.

    Article  PubMed  CAS  Google Scholar 

  15. Hoffmann P, et al. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389–99.

    Article  PubMed  CAS  Google Scholar 

  16. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002;99:3493–9.

    Article  PubMed  CAS  Google Scholar 

  17. Taylor PA, et al. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GvHD and BM graft rejection. Blood 2004;104:3804–12.

    Article  PubMed  CAS  Google Scholar 

  18. Trenado A, et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest. 2003;112:1688–96.

    PubMed  CAS  Google Scholar 

  19. Wagner JE, et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214–9.

    Article  PubMed  CAS  Google Scholar 

  20. Wagner JE, Kurtzberg J. Allogeneic umbilical cord blood transplantation. In: Broxmeyer HE, editor. Cellular characteristics of cord blood and cord blood transplantation. Bethesda, MA: AABB Press; 1998. p. 113–46.

    Google Scholar 

  21. Gluckman E, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373–81.

    Article  PubMed  CAS  Google Scholar 

  22. Rocha V, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846–54.

    Article  PubMed  CAS  Google Scholar 

  23. Kurtzberg J, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157–66.

    Article  PubMed  CAS  Google Scholar 

  24. Wagner JE, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795–802.

    PubMed  CAS  Google Scholar 

  25. Rubinstein P, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–77.

    Article  PubMed  CAS  Google Scholar 

  26. Gluckman E, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397–407.

    Article  PubMed  CAS  Google Scholar 

  27. Rubinstein P, Stevens CE. Placental blood for bone marrow replacement: the New York Blood Center’s program and clinical results. Baillieres Best Pract Res Clin Haematol. 2000;13:565–84.

    Article  PubMed  CAS  Google Scholar 

  28. Wagner JE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611–8.

    PubMed  CAS  Google Scholar 

  29. Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D, Wagner JE, Kurtzberg J. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006 Feb;12(2):184–94.

    Google Scholar 

  30. Laporte JP, et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. N Engl J Med. 1996;335:167–70.

    Article  PubMed  CAS  Google Scholar 

  31. Laughlin MJ, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815–22.

    Article  PubMed  CAS  Google Scholar 

  32. Rocha V, et al. Prognostic factors of outcome after unrelated cord blood transplant (UCBT) in adults with hematologic malignancies. Blood 2000;96:587a.

    Google Scholar 

  33. Sanz GF, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001;98:2332–8.

    Article  PubMed  CAS  Google Scholar 

  34. Laporte JP, et al. Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience. Bone Marrow Transplant. 1998;22 Suppl 1:S76–7.

    PubMed  Google Scholar 

  35. Arcese W, et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 2006;91:223–30.

    PubMed  Google Scholar 

  36. Cornetta K, et al. Umbilical cord blood transplantation in adults: results of the prospective cord blood transplantation (COBLT). Biol Blood Marrow Transplant. 2005;11:149–60.

    Article  PubMed  Google Scholar 

  37. Iori AP, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant. 2004;33:1097–105.

    Article  PubMed  CAS  Google Scholar 

  38. Long GD, et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2003;9:772–80.

    Article  PubMed  Google Scholar 

  39. Ooi J, et al. Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia. Br J Haematol. 2001;114:834–6.

    Article  PubMed  CAS  Google Scholar 

  40. Tomonari A, et al. Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation. Eur J Haematol. 2006;77:46–50.

    Article  PubMed  CAS  Google Scholar 

  41. Barker JN, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005;105:1343–7.

    Article  PubMed  CAS  Google Scholar 

  42. Konuma T, et al. Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years. Bone Marrow Transplant. 2006;37:803–4.

    Article  PubMed  CAS  Google Scholar 

  43. Ooi J, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489–91.

    Article  PubMed  CAS  Google Scholar 

  44. Kai S, et al. Double-unit cord blood transplantation in Japan. Blood 2004;104:5166a.

    Google Scholar 

  45. Ooi J. The efficacy of unrelated cord blood transplantation for adult myelodysplastic syndrome. Leuk Lymphoma. 2006;47:599–602.

    Article  PubMed  Google Scholar 

  46. Barker JN, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97:2957–61.

    Article  PubMed  CAS  Google Scholar 

  47. Eapen M, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007;369:1947–54.

    Article  PubMed  Google Scholar 

  48. Meyer EA, et al. Cord blood: establishing a national cord blood stem cell bank program. Washington: The National Academy Press; 2005.

    Google Scholar 

  49. Adamkiewicz TV, et al. Unrelated cord blood transplantation in children with sickle cell disease: US centers experience. Blood 2005;106:2044.

    Google Scholar 

  50. Fang J, et al. Umbilical cord blood transplantation in Chinese children with beta-thalassemia. J Pediatr Hematol Oncol. 2004;26:185–9.

    Article  PubMed  Google Scholar 

  51. Jaing TH, et al. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biol Blood Marrow Transplant. 2005;11:349–53.

    Article  PubMed  Google Scholar 

  52. Locatelli F, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137–43.

    Article  PubMed  CAS  Google Scholar 

  53. Miniero R, et al. Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord. Bone Marrow Transplant. 1998;22 Suppl 1:S78–9.

    Google Scholar 

  54. Walters MC, et al. Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann N Y Acad Sci. 2005;1054:206–13.

    Article  PubMed  Google Scholar 

  55. Martin PL, et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006;12:184–94.

    Article  PubMed  Google Scholar 

  56. Escolar ML, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease. N Engl J Med. 2005;352:2069–81.

    Article  PubMed  CAS  Google Scholar 

  57. Staba SL, et al. Cord-blood transplants from unrelated donors in patients with Hurler’s syndrome. N Engl J Med. 2004;350:1960–9.

    Article  PubMed  CAS  Google Scholar 

  58. Rocha V, et al. Results of unrelated cord blood versus unrelated bone marrow transplant in adults with acute leukemia. A matched pair analysis. Blood 2002;100:42a.

    Article  Google Scholar 

  59. Laughlin MJ, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75.

    Article  PubMed  CAS  Google Scholar 

  60. Takahashi S, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004;104:3813–20.

    Article  PubMed  CAS  Google Scholar 

  61. Hwang WY, et al. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant. 2007;13:444–53.

    Article  PubMed  Google Scholar 

  62. Rocha V, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.

    Article  PubMed  CAS  Google Scholar 

  63. van Heeckeren WJ, et al. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. Br J Haematol. 2007;139:464–74.

    Article  PubMed  Google Scholar 

  64. Brunstein CG, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplant outcomes in 110 adults with hematological disease. Blood 2007;110(8):3064–70.

    Google Scholar 

  65. Brunstein CG, Wagner JE. Cord blood transplantation for adults. Vox Sang. 2006;91:195–205.

    Article  PubMed  Google Scholar 

  66. Majhail NS, Brunstein CG, Wagner JE. Double umbilical cord blood transplantation. Curr Opin Immunol. 2006;18:571–5.

    Article  PubMed  CAS  Google Scholar 

  67. Rocha V, et al. Reduced intensity conditioning regimen in single unrelated cord blood transplantation in adults with hematological malignant disorders. An Eurocord-Netcord and SFGM-TC survey. Blood 2006;108:897a.

    Google Scholar 

  68. Hamza NS, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol. 2004;124:488–98.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Minnesota, Minneapolis, MN, USA

    John E. Wagner

Authors
  1. John E. Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudio Brunstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William Tse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mary Laughlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John E. Wagner .

Editor information

Editors and Affiliations

  1. Weeping Cherry Drive 14015 , Rockville, 20850, U.S.A.

    Michael R. Bishop

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Wagner, J.E., Brunstein, C., Tse, W., Laughlin, M. (2009). Umbilical Cord Blood Transplantation. In: Bishop, M. (eds) Hematopoietic Stem Cell Transplantation. Cancer Treatment and Research, vol 144. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78580-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-78580-6_10

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-78579-0

  • Online ISBN: 978-0-387-78580-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation